QYO

Hematopoietic Cell Enrichment Kit

Product code
QYO
Device name
Hematopoietic Cell Enrichment Kit
Device class
Class 2
21 CFR
21 CFR 866.6120
Medical specialty
Immunology
Marketing pathway
510(K)
510(k) clearances (last 3 years)
1
Summaries archived here
0 (direct download)
510(k) clearances (all years, FDA)
1 (all years; only the last 3 years are listed here)

FDA classification definition

A hematopoietic cell enrichment kit is an in vitro diagnostic device intended for the selection and enrichment of specific hematopoietic cells from human whole blood and/or bone marrow collected from patients with hematological malignancies using immunomagnetic bead-based selection. It is intended for use with diagnostic assays as part of the pre-analytical workflow.

Definition text from the FDA device classification database (U.S. federal government work, public domain).

510(k) clearances, last 3 years (1)

Last three years. Most recent: 2023-11-06.

NumberDecision dateApplicantDevice nameSummary
DEN2200902023-11-06Stemcell Technologies Canada, Inc.EasySep™ Human Bone Marrow CD138 Positive Selection …
Official FDA classification page: QYO
Classification and pathway per current FDA publications. Data from openFDA (CC0).